Early research (Phase 1)Ended earlyNCT02566759
What this trial is testing
A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants
Who this might be right for
Schizophrenia, Cerebellar Ataxia
Neurocrine Biosciences 110
Showing 2 of 2 results